Bone conduction solutions for adults

Bone conduction solutions have the potential to make everyday activities less stressful and more enjoyable. Learn how they may be able to help you.

What you’ll find on this page

  • Find out if you qualify for a bone conduction solution

  • Learn about the benefits of bone conduction solutions

  • Find out how you can try out a Cochlear™ bone conduction solution

“I was born with a nonfunctional eardrum in my right ear and a fused stapes in both ears. I had five surgeries, and every time it was such a disappointment. I thought this was it. This is what I'd live with for the rest of my life. Once [I got] my Baha, it was amazing. I came out of a cocoon, basically. I'm happier. I'm out more. I'm active more. I'm enjoying other people more.”

-Anne S. - Baha® recipient

View all stories

Do you qualify for a bone conduction solution?

Bone conduction solutions can help people with single-sided deafness, conductive hearing loss and mixed hearing loss. They are proven hearing solutions for Microtia and Atresia and hearing loss due to illness or ear infections.

Will you benefit from a bone conduction solution?

Research and decades of experience demonstrate that a bone conduction solution may help you:1-5

  • Hear better, even in noisy situations2

  • Enjoy a clean, more natural sound because bypassing the damaged part of your ear may reduce the amount of amplification needed to help you hear better2

  • Hear sounds as if they are coming from both sides3

  • Become more aware of your surroundings, increasing your ability to hear important sounds4

Try a bone conduction solution, then decide

If you've been told that a bone conduction hearing solution is a treatment option for your hearing loss, you can try a Cochlear bone conduction solution before deciding whether to get an implant. Make an appointment with a hearing health professional who specializes in hearing implant technology and they will be able to advise you if you may benefit from a bone conduction solution. Find one today.

Introducing the Cochlear™ Osia® System

The Cochlear™ Osia® System is the world’s first osseointegrated, steady-state active system. With this new system, we have revolutionized bone conduction technology. Vibrations are created by the transducer located under the skin, creating direct bone conduction to the inner ear. This state-of-the-art design helps create optimal sound transmission to the inner ear. Fully featured with our innovative sound processing and connectivity technologies, the Osia System is designed to provide your best hearing, particularly in noisy environments.

The Cochlear™ Baha® 5 Implant Systems

Cochlear offers a choice of bone conduction implant systems that use the same implant but connect in different ways with the Baha 5 Implant System.The Baha Connect System is an abutment connection, and the Baha Attract System is a magnetic connection. Unlike the Osia System where the sound vibrations are sent to the bone from the internal implant, the vibrations are sent to the bone from the external sound processor. The Baha 5 Systems offer choices of sound processor power capabilities, Apple® and Android™ compatibility and advanced wireless connectivity solutions so you can benefit from better hearing today and into the future.

Want more information about bone conduction solutions?

We can send you a free informational guide on bone conduction implants today.

Request now

Lady using an iPad at the park

Contact us

Get in touch with Cochlear


Please seek advice from your medical practitioner or health professional about treatments for hearing loss. They will be able to advise on a suitable solution for the hearing loss condition. All products should be used only as directed by your medical practitioner or health professional. Not all products are available in all countries. Please contact your local Cochlear representative.

Views expressed by Cochlear recipients and hearing health providers are those of the individual. Consult your hearing health provider to determine if you are a candidate for Cochlear technology. Outcomes and results may vary.

ACE, Advance Off-Stylet, AOS, AutoNRT, Autosensitivity, Beam, Button, CareYourWay, Carina, Cochlear, 科利耳, コクレア, Cochlear SoftWear, Codacs, ConnectYourWay, Contour, Contour Advance, Custom Sound, ESPrit, Freedom, Hear now. And always, HearYourWay, Hugfit, Hybrid, Invisible Hearing, Kanso, MET, MicroDrive, MP3000, myCochlear, mySmartSound, NRT, Nucleus, Off-Stylet, Slimline, SmartSound, Softip, SPrint, True Wireless, the elliptical logo, WearYourWay and Whisper are either trademarks or registered trademarks of Cochlear Limited. Ardium, Baha, Baha SoftWear, BCDrive, DermaLock, EveryWear, Vistafix, and WindShield are either trademarks or registered trademarks of Cochlear Bone Anchored Solutions AB.

Apple, iPhone, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries.

Android and Google Play are registered trademarks of Google Inc.


  1. Lin LM, Bowditch S, Anderson MJ, May B, Cox KM, Niparko K. “Amplification in the rehabilitation of unilateral deafness: speech in noise and directional hearing effects with bone-anchored hearing and contralateral routing of signal amplification.” Otology & Neurotology. 2006;27(2):172-82.
  2. Flynn MC, Sadeghi A, Halvarsson G. Baha solutions for patients with severe mixed hearing loss. Cochlear Implants Int 2009;10 Suppl 1:43-7.
  3. Hol MK, Snik AF, Mylanus EA, Cremers CW. Long-term results of bone anchored hearing aid recipients who had previously used air-conduction hearing aids. Arch Otolaryngol Head Neck Surg 2005 Apr;131(4):321-5.
  4. Watson GJ, Silva S, Lawless T, Harling JL, Sheehan PZ. Bone anchored hearing aids: a preliminary assessment of the impact on outpatients and cost when rehabilitating hearing in chronic suppurative otitis media. Clin Otolaryngol 2008;33:338–342.
  5. Snik AF, Mylanus EA, Proops DW, Wolfaardt J, Hodgetts WA, Somers T, Niparko JK, Wazen JJ, Sterkers O, Cremers CW, Tjellström A. Consensus statements on the Baha system: Where do we stand at present? Ann Otol Rhinol Laryngol 2005 Dec;114(12) Suppl 195:1-12.